{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:28:40Z","timestamp":1791494920088,"version":"4.3.4"},"reference-count":42,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221152\/Z\/20\/Z"],"award-info":[{"award-number":["221152\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Clinician Scientist Fellowship Programme","award":["(CS-2017-17-007)"],"award-info":[{"award-number":["(CS-2017-17-007)"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,16]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To capture UK medical students\u2019 self-reported knowledge and harm assessment of psychedelics and to explore the factors associated with support for changing the legal status of psychedelics to facilitate further clinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>UK medical schools recognised by the General Medical Council.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1\u20136) in medical school.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students\u2019 harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p&lt;0.001), lower estimated harm scores (p&lt;0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-083595","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:01:20Z","timestamp":1710457280000},"page":"e083595","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["UK medical students\u2019 self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study"],"prefix":"10.1136","volume":"14","author":[{"given":"Charlie","family":"Song-Smith","sequence":"first","affiliation":[{"name":"UCL Medical School, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, UK"},{"name":"Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4647-8088","authenticated-orcid":false,"given":"James","family":"Rucker","sequence":"additional","affiliation":[{"name":"The Department of Psychological Medicine, King's College London, London, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Saint","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cooke","sequence":"additional","affiliation":[{"name":"Innerspace Institute, Alentejo, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-0749","authenticated-orcid":false,"given":"Marco","family":"Schlosser","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, UCL, London, UK"},{"name":"Institut f\u00fcr Psychotherapie Potsdam, Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2025121402390326000_14.3.e083595.1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.84"},{"key":"2025121402390326000_14.3.e083595.2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"2025121402390326000_14.3.e083595.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.020"},{"key":"2025121402390326000_14.3.e083595.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.12.040"},{"key":"2025121402390326000_14.3.e083595.5","doi-asserted-by":"publisher","DOI":"10.1055\/a-1310-3990"},{"key":"2025121402390326000_14.3.e083595.6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging new paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin Pharma and Therapeutics"},{"key":"2025121402390326000_14.3.e083595.7","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13249"},{"key":"2025121402390326000_14.3.e083595.8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and Psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"AJP"},{"key":"2025121402390326000_14.3.e083595.9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic Psychedelics: an integrative review of epidemiology, Therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"2025121402390326000_14.3.e083595.10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of Psychedelic drugs: A systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"2025121402390326000_14.3.e083595.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"2025121402390326000_14.3.e083595.12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose Psilocybin treatment for major depressive disorder: A randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"2025121402390326000_14.3.e083595.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101809","article-title":"Single-dose Psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025121402390326000_14.3.e083595.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.108"},{"key":"2025121402390326000_14.3.e083595.15","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.nsa.2022.100104","article-title":"Methodological challenges in Psychedelic drug trials: efficacy and safety of Psilocybin in treatment-resistant major depression (episode) \u2013 rationale and study design","volume":"1","author":"Mertens","year":"2022","journal-title":"Neuroscience Applied"},{"key":"2025121402390326000_14.3.e083595.16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med"},{"key":"2025121402390326000_14.3.e083595.17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881120965915","article-title":"A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis","volume":"35","author":"Illingworth","year":"2021","journal-title":"J Psychopharmacol"},{"key":"2025121402390326000_14.3.e083595.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.003"},{"key":"2025121402390326000_14.3.e083595.19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15622975.2023.2169349","article-title":"Oral ketamine for depression: an updated systematic review","volume":"24","author":"Meshkat","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"2025121402390326000_14.3.e083595.20","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"2025121402390326000_14.3.e083595.21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamapsychiatry.2023.0549","article-title":"Emerging challenges for Psychedelic therapy","volume":"80","author":"Aday","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2025121402390326000_14.3.e083595.22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/psymed.2023.0013","article-title":"Psychedelic commercialization: A wide-spanning overview of the emerging Psychedelic industry","volume":"1","author":"Aday","year":"2023","journal-title":"Psychedelic Medicine"},{"key":"2025121402390326000_14.3.e083595.23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/02791072.2021.1957183","article-title":"Psychedelic knowledge and opinions in psychiatrists at two professional conferences: an exploratory survey","volume":"54","author":"Barnett","year":"2022","journal-title":"J Psychoactive Drugs"},{"key":"2025121402390326000_14.3.e083595.24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/NMD.0000000000000828","article-title":"A survey of American psychiatrists\u2019 attitudes toward classic Hallucinogens","volume":"206","author":"Barnett","year":"2018","journal-title":"J Nerv Ment Dis"},{"key":"2025121402390326000_14.3.e083595.25","doi-asserted-by":"crossref","unstructured":"Barnett BS , Arakelian M , Beebe D , et al . American psychiatrists\u2019 opinions about classic Hallucinogens and their potential therapeutic applications: A 7-year follow-up survey. Psychedelic Medicine 2023. doi:10.1089\/psymed.2023.0036","DOI":"10.1089\/psymed.2023.0036"},{"key":"2025121402390326000_14.3.e083595.26","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.743599","article-title":"The readiness of psychiatrists to implement Psychedelic-assisted psychotherapy","volume":"12","author":"Page","year":"2021","journal-title":"Front Psychiatry"},{"key":"2025121402390326000_14.3.e083595.27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/02791072.2021.1971343","article-title":"Attitudes and beliefs about the therapeutic use of Psychedelic drugs among psychologists in the United States","volume":"54","author":"Davis","year":"2022","journal-title":"J Psychoactive Drugs"},{"key":"2025121402390326000_14.3.e083595.28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jcad.12429","article-title":"Counselors\u2019 attitudes toward Psychedelics and their use in therapy","volume":"100","author":"Hearn","year":"2022","journal-title":"Jour of Counseling &Amp; Develop"},{"key":"2025121402390326000_14.3.e083595.29","article-title":"Predictors of medical students\u2019 perceptions of Psilocybin-assisted therapy for use in medical practice","volume":"15","author":"Wang","year":"2023","journal-title":"Cureus"},{"key":"2025121402390326000_14.3.e083595.30","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1190507","article-title":"Medical student attitudes and perceptions of Psychedelic-assisted therapies","volume":"14","author":"Li","year":"2023","journal-title":"Front Psychiatry"},{"key":"2025121402390326000_14.3.e083595.31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/psymed.2023.0022","article-title":"Medical students' attitudes and beliefs toward Psilocybin: does terminology and personal experience with Psychedelics matter?","volume":"1","author":"Pag\u00e1n","year":"2023","journal-title":"Psychedelic Medicine"},{"key":"2025121402390326000_14.3.e083595.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021109","article-title":"Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people","volume":"8","author":"Cheeta","year":"2018","journal-title":"BMJ Open"},{"key":"2025121402390326000_14.3.e083595.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61462-6"},{"key":"2025121402390326000_14.3.e083595.34","unstructured":"Prohibition Partners . PSYCH: the Psychedelics as medicine report second edition; 2020."},{"key":"2025121402390326000_14.3.e083595.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrp.2006.02.001"},{"key":"2025121402390326000_14.3.e083595.36","unstructured":"John OP , Srivastava S . The big five trait Taxonomy: history, measurement, and theoretical perspectives. In: Handbook of personality: Theory and research. 2nd ed. New York, NY, US: Guilford Press, 1999: 102\u201338."},{"key":"2025121402390326000_14.3.e083595.37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with Lysergic acid Diethylamide and Psilocybin mushrooms: findings from the global drug survey 2020","volume":"37","author":"Kopra","year":"2023","journal-title":"J Psychopharmacol"},{"key":"2025121402390326000_14.3.e083595.38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jamapsychiatry.2023.3867","article-title":"Use of Lysergic acid Diethylamide by major depression status","volume":"81","author":"Walsh","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"2025121402390326000_14.3.e083595.39","doi-asserted-by":"crossref","first-page":"1224551","DOI":"10.3389\/fpsyt.2023.1224551","article-title":"Slouching towards engagement: interactions between people using Psychedelics Naturalistically and their Healthcare providers","volume":"14","author":"Boehnke","year":"2023","journal-title":"Front Psychiatry"},{"key":"2025121402390326000_14.3.e083595.40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic Psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online Psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"2025121402390326000_14.3.e083595.41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/psymed.2022.0004","article-title":"Personal Psychedelic use is common among a sample of Psychedelic therapists: implications for research and practice","volume":"1","author":"Aday","year":"2023","journal-title":"Psychedelic Medicine"},{"key":"2025121402390326000_14.3.e083595.42","doi-asserted-by":"crossref","unstructured":"Song-Smith C , Jacobs E , Rucker J , et al . UK medical students\u2019 self-reported knowledge and harm assessment of Psychedelics and their application in clinical research: a cross-sectional study. Open Science Framework [https:\/\/osf.io\/tmp3u\/] 2023. doi:10.17605\/OSF.IO\/TMP3U","DOI":"10.1101\/2023.12.21.23300364"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-083595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T10:39:10Z","timestamp":1765708750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-083595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,14]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-083595"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-083595","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.21.23300364","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}